|1.||Mecchi, Michael S: 1 article (07/2010)|
|2.||Johnson, Mark S: 1 article (07/2010)|
|3.||Song, Jian: 1 article (07/2010)|
|4.||Reddy, Gunda: 1 article (07/2010)|
|5.||Wang, Bin: 1 article (10/2006)|
|6.||Song, Haibin: 1 article (10/2006)|
|7.||Xu, Shansheng: 1 article (10/2006)|
|8.||Wang, Baiquan: 1 article (10/2006)|
|9.||Li, Minxiong: 1 article (10/2006)|
|1.||Dehydration (Water Stress)
04/01/1984 - "Compounds with phenyl (2b) and butyl (2c) substituents were prepared by the addition of phenyllithium and n-butyllithium, respectively, to (-)-9-nor-9-oxohexahydrocannabinol (1), followed by dehydration, whereas, isopropyl (2d), PhCH2 (2e), and Ph(CH2)2 (2f) derivatives were synthesized via the Grignard reaction with subsequent dehydration. "
10/13/2006 - "The reaction of dibenzofuran 1, lithium pieces (2.2 equiv), and TMEDA (2.2 equiv) in dry ether under reflux led to a solution of the corresponding C,O-dilithiated intermediate 2 which, upon treatment with different ketones or aldehydes (0.8 equiv) at -78 degrees C, afforded, after hydrolysis and dehydration, 6,6-substituted-6H-dibenzo[b,d]pyrans 3 in good yields. "
|2.||Chromosome Aberrations (Chromosome Abnormalities)
07/19/2010 - "TMEDA produced a positive response in this system, with or without metabolic activation, but only at the highest concentration, 5mg/mL. However, according to the OECD guideline TG 473, the compound is considered to be negative in the CHO chromosomal aberration assay, since the compound was not clastogenic at 0.01M (1.140mg/mL). "
|4.||Ethyl Ether (Ether)